Diabetes Dialogue: SURMOUNT-3 and -4 Inform Use of Tirzepatide in Obesity
In this episode, hosts discuss the results of SURMOUNT-3 and SURMOUNT-4 as well as how it might help inform use of tirzepatide if approved by the US Food and Drug Administration for chronic weight management.